4
Changes in Ownership
RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-058701
Director sold 11,447 shares at $7.40 ($84,693)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Borgeson Blake · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-12 | Sale : show line 1 in the form 10b5-1 | −11,447 | $7.40 | $84,693 | 7,384,526 | D |
| Open-market sales · 11,447 sh · avg $7.40 · $84,693 | ||||||
Loading xslF345X05/doc4.xml…